Rifaximin, a semi-synthetic, non-systemic antibiotic derived from rifamycin, is a critical active pharmaceutical ingredient (API) used in the treatment of traveler's diarrhea, irritable bowel syndrome with diarrhea (IBS-D), and hepatic encephalopathy. As global demand for this API continues to rise, pharmaceutical manufacturers, bulk drug importers, and procurement teams are closely tracking the Rifaximin price across key manufacturing and consuming regions.
This quarter, pricing data from North America, Asia-Pacific (APAC), and Europe shows a consistent upward trend, with all three regions posting quarter-over-quarter increases above 10%. Below, we break down the numbers region by region, explain what is driving the increase, and offer a forecast outlook for buyers and suppliers alike.
North America: Rifaximin Price Driven by Freight Costs
In the United States, the Rifaximin Price Index rose by 10.1036% quarter-over-quarter, making it the fastest-growing region this quarter. The average Rifaximin price settled at approximately USD 137,053.33 per metric ton, based on CFR Los Angeles assessments.
Why US Rifaximin Prices Rose
The primary driver behind the North American increase is freight-driven landed cost inflation. As CFR (Cost and Freight) pricing incorporates ocean freight, bunker fuel surcharges, and port handling fees directly into the landed cost, any tightening in shipping capacity or rise in fuel costs is passed through to the final import price. West Coast port congestion, container availability constraints, and elevated trans-Pacific freight rates have all contributed to higher landed costs for pharmaceutical API importers bringing Rifaximin into Los Angeles.
For US-based generic drug manufacturers and API distributors, this means procurement budgets need to account not just for ex-works API cost, but for a growing freight premium that is increasingly volatile quarter to quarter.
APAC: China's Rifaximin Price Reflects Feedstock and Export Demand
In China, the world's largest API manufacturing base, the Rifaximin Price Index increased by 10.06% quarter-over-quarter. The average price for the quarter came in at approximately USD 136,880.00 per metric ton, based on FOB (Free on Board) shipment terms.
Why China's Rifaximin Prices Rose
Two structural factors are behind China's price movement:
- Firmer feedstock pricing — Rifaximin production relies on rifamycin-derived intermediates, and any tightening in the upstream fermentation-based feedstock supply chain raises the cost of API manufacturing.
- Stronger export demand — Global pharmaceutical buyers, particularly generic manufacturers in India, Europe, and North America, have increased offtake volumes, pushing Chinese exporters to raise FOB quotations in response to tighter available capacity.
Because China's Rifaximin pricing is quoted FOB rather than CFR, it does not include destination freight — meaning importing countries typically see a further markup once shipping and insurance costs are added on top of the China FOB baseline.
Europe: Germany's Rifaximin Price Rises on Higher Landed Costs
In Germany, a key European pharmaceutical import and distribution hub, the Rifaximin Price Index rose by 10.08% quarter-over-quarter. The average price for the quarter was approximately USD 137,023.33 per metric ton, including CFR Hamburg shipments.
Why Germany's Rifaximin Prices Rose
Similar to the US market, Germany's price increase is closely tied to higher landed costs on CFR Hamburg shipments. As one of Europe's busiest pharmaceutical import gateways, Hamburg's landed pricing reflects a combination of:
- Elevated long-haul ocean freight rates from Asian manufacturing origins
- Currency fluctuations affecting USD-denominated freight and insurance costs
- Regulatory and quality-compliance costs associated with EU GMP import requirements
Germany's price level — sitting almost exactly between the US and China figures — reinforces the pattern of a globally synchronized Rifaximin market where regional differences are driven more by logistics and Incoterms than by fundamentally different supply-demand conditions.
Rifaximin Price Comparison: CFR vs. FOB — What Buyers Should Know
A common point of confusion when comparing Rifaximin prices across regions is the difference in trade terms:
- FOB (Free on Board) — as used for China pricing — reflects the cost of the API loaded onto the vessel at the port of origin, excluding freight and insurance to the destination.
- CFR (Cost and Freight) — as used for USA and Germany pricing — includes the cost of the goods plus freight to the destination port, but excludes insurance.
This distinction matters enormously for procurement teams benchmarking prices. A China FOB quote of USD 136,880.00/MT is not directly comparable to a USA CFR quote of USD 137,053.33/MT without first adding estimated freight, insurance, and import duties to the China figure. Once freight is factored in, the effective landed cost gap between regions narrows even further, underscoring just how tightly interlinked the global Rifaximin trade has become.
What's Driving the Global Rifaximin Price Increase This Quarter?
Across all three regions, three consistent themes emerge:
- Freight and logistics costs are the single largest contributor to the North American and European price increases, given their reliance on CFR-based landed pricing.
- Feedstock tightness in China is raising ex-works manufacturing costs, which then ripple downstream to every importing region.
- Demand strength — both from generic drug manufacturers replenishing inventory and from growing prescription volumes for IBS-D and hepatic encephalopathy therapies — is keeping buyers willing to absorb higher prices rather than delay procurement.
Together, these factors explain why the Rifaximin Price Index rose by a remarkably similar margin (10.06%–10.1036%) in three very different regional markets during the same quarter — a strong signal that this is a global cost-push cycle rather than a localized anomaly.
Rifaximin Price Outlook: What to Expect Next Quarter
While pricing data is inherently backward-looking, the underlying drivers — freight rates, feedstock costs, and export demand — tend to move in multi-quarter cycles rather than reversing sharply overnight. Buyers and procurement planners should watch for:
- Ocean freight rate movements, particularly trans-Pacific and Asia-Europe lanes, as the single biggest swing factor for CFR-based pricing in the US and Germany
- Chinese feedstock and fermentation capacity utilization, which will determine whether FOB pricing continues to climb or stabilizes
- Seasonal demand patterns in generic pharmaceutical manufacturing, which typically pick up ahead of year-end inventory cycles
Given the tight correlation across regions this quarter, any easing in global freight rates would likely be the fastest route to price relief across all three markets simultaneously.
Conclusion
This quarter's data confirms a clear, synchronized upward trend in the global Rifaximin price, with North America, APAC, and Europe all posting quarter-over-quarter increases above 10%. The USA leads at USD 137,053.33/MT CFR Los Angeles, closely followed by Germany at USD 137,023.33/MT CFR Hamburg, and China at USD 136,880.00/MT FOB. Freight-driven landed costs, tighter feedstock supply, and robust export demand are the common threads tying these regional movements together. For pharmaceutical procurement teams and API buyers, staying ahead of these trends — and understanding the FOB versus CFR pricing distinction — will be essential to managing sourcing costs in the quarters ahead.
Frequently Asked Questions About Rifaximin Price
What is the current average Rifaximin price in the USA?
The average Rifaximin price in the USA for the quarter was approximately USD 137,053.33 per metric ton, based on CFR Los Angeles assessments.
What is the Rifaximin price in China?
China's average Rifaximin price was approximately USD 136,880.00 per metric ton on an FOB basis.
What is the Rifaximin price in Germany?
Germany's average Rifaximin price was approximately USD 137,023.33 per metric ton, including CFR Hamburg shipments.
Why did Rifaximin prices increase this quarter?
Prices rose due to a combination of freight-driven landed cost increases, firmer feedstock pricing in China, and stronger global export demand for the API.
Which region has the highest Rifaximin price?
The USA currently has the highest average Rifaximin price among the three tracked regions, at approximately USD 137,053.33/MT CFR Los Angeles.
Is the Rifaximin price increase expected to continue?
Given that freight and feedstock costs tend to move in multi-quarter cycles, prices are likely to remain elevated in the near term unless there is a notable easing in global shipping rates or feedstock availability.
Comments